| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 115 | 2025 | 716 | 16.440 |
Why?
|
| Trophoblasts | 73 | 2025 | 190 | 11.340 |
Why?
|
| Fetal Growth Retardation | 46 | 2025 | 543 | 5.420 |
Why?
|
| Fetal Development | 31 | 2025 | 283 | 4.510 |
Why?
|
| Pregnancy | 159 | 2025 | 6357 | 4.160 |
Why?
|
| TOR Serine-Threonine Kinases | 40 | 2025 | 380 | 4.120 |
Why?
|
| Docosahexaenoic Acids | 9 | 2024 | 83 | 3.900 |
Why?
|
| Pregnancy Complications | 22 | 2024 | 487 | 3.650 |
Why?
|
| Amino Acids | 23 | 2024 | 474 | 3.150 |
Why?
|
| Maternal-Fetal Exchange | 25 | 2021 | 161 | 3.090 |
Why?
|
| Diabetes, Gestational | 21 | 2023 | 307 | 3.080 |
Why?
|
| Phospholipids | 7 | 2024 | 207 | 2.990 |
Why?
|
| Obesity | 28 | 2025 | 2858 | 2.800 |
Why?
|
| Dietary Supplements | 7 | 2024 | 531 | 2.420 |
Why?
|
| Amino Acid Transport System A | 17 | 2025 | 37 | 2.350 |
Why?
|
| Fetus | 13 | 2024 | 760 | 1.970 |
Why?
|
| Birth Weight | 15 | 2022 | 498 | 1.970 |
Why?
|
| Biological Transport | 32 | 2024 | 394 | 1.940 |
Why?
|
| Fatty Acids | 10 | 2024 | 415 | 1.930 |
Why?
|
| Amino Acid Transport Systems | 17 | 2024 | 42 | 1.920 |
Why?
|
| Adiponectin | 15 | 2024 | 234 | 1.880 |
Why?
|
| Insulin | 27 | 2023 | 2315 | 1.840 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2018 | 95 | 1.840 |
Why?
|
| Body Mass Index | 16 | 2024 | 2261 | 1.690 |
Why?
|
| Cell Membrane | 29 | 2020 | 720 | 1.680 |
Why?
|
| Fetal Macrosomia | 12 | 2023 | 62 | 1.670 |
Why?
|
| Fetal Blood | 7 | 2024 | 316 | 1.600 |
Why?
|
| Female | 168 | 2025 | 68154 | 1.530 |
Why?
|
| Pregnancy in Diabetics | 9 | 2021 | 118 | 1.460 |
Why?
|
| Signal Transduction | 40 | 2025 | 4826 | 1.400 |
Why?
|
| Oleic Acid | 3 | 2014 | 39 | 1.330 |
Why?
|
| Microvilli | 22 | 2019 | 77 | 1.280 |
Why?
|
| Pregnancy Trimester, First | 12 | 2020 | 138 | 1.260 |
Why?
|
| Folic Acid | 7 | 2021 | 184 | 1.250 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2023 | 137 | 1.200 |
Why?
|
| Carrier Proteins | 10 | 2021 | 732 | 1.180 |
Why?
|
| Insulin-Like Growth Factor I | 11 | 2023 | 307 | 1.170 |
Why?
|
| Pregnancy Proteins | 5 | 2022 | 37 | 1.140 |
Why?
|
| Choline | 3 | 2024 | 119 | 1.120 |
Why?
|
| Glucose Transporter Type 1 | 10 | 2023 | 48 | 1.080 |
Why?
|
| Lysophosphatidylcholines | 3 | 2024 | 19 | 1.050 |
Why?
|
| Folate Receptor 1 | 4 | 2019 | 15 | 1.030 |
Why?
|
| Humans | 144 | 2025 | 128418 | 0.990 |
Why?
|
| Palmitic Acid | 2 | 2014 | 40 | 0.930 |
Why?
|
| Fatty Acid Transport Proteins | 4 | 2018 | 18 | 0.930 |
Why?
|
| Phosphatidylcholines | 5 | 2024 | 146 | 0.930 |
Why?
|
| Glucose | 16 | 2022 | 982 | 0.890 |
Why?
|
| Amino Acid Transport System L | 8 | 2025 | 19 | 0.880 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 10 | 2024 | 169 | 0.880 |
Why?
|
| Symporters | 1 | 2023 | 54 | 0.860 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 13 | 2024 | 115 | 0.850 |
Why?
|
| Reduced Folate Carrier Protein | 3 | 2019 | 10 | 0.840 |
Why?
|
| Glucose Intolerance | 5 | 2022 | 142 | 0.830 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 2505 | 0.830 |
Why?
|
| Adult | 55 | 2025 | 35300 | 0.820 |
Why?
|
| Adiposity | 5 | 2021 | 504 | 0.820 |
Why?
|
| Lipoprotein Lipase | 5 | 2018 | 58 | 0.810 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 4 | 2004 | 51 | 0.800 |
Why?
|
| Glycerol | 1 | 2022 | 87 | 0.790 |
Why?
|
| Insulin Resistance | 7 | 2022 | 1164 | 0.790 |
Why?
|
| Multiprotein Complexes | 6 | 2015 | 147 | 0.790 |
Why?
|
| Lipids | 5 | 2022 | 620 | 0.770 |
Why?
|
| Cells, Cultured | 22 | 2020 | 4001 | 0.760 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2022 | 563 | 0.750 |
Why?
|
| Gestational Age | 22 | 2021 | 867 | 0.750 |
Why?
|
| Lipid Metabolism | 4 | 2018 | 491 | 0.740 |
Why?
|
| Proton-Coupled Folate Transporter | 3 | 2019 | 10 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2022 | 421 | 0.720 |
Why?
|
| Preconception Care | 1 | 2021 | 39 | 0.700 |
Why?
|
| Infant, Newborn | 25 | 2022 | 5687 | 0.700 |
Why?
|
| Calcium | 7 | 2003 | 1178 | 0.680 |
Why?
|
| Membrane Transport Proteins | 6 | 2023 | 148 | 0.670 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 1212 | 0.660 |
Why?
|
| Primary Cell Culture | 7 | 2019 | 158 | 0.630 |
Why?
|
| Fetal Nutrition Disorders | 3 | 2015 | 7 | 0.630 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2019 | 51 | 0.620 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 8 | 2023 | 58 | 0.610 |
Why?
|
| Triglycerides | 4 | 2022 | 523 | 0.610 |
Why?
|
| Phosphorylation | 12 | 2023 | 1681 | 0.610 |
Why?
|
| Animals | 64 | 2025 | 34479 | 0.600 |
Why?
|
| Arachidonic Acid | 2 | 2017 | 114 | 0.580 |
Why?
|
| PPAR alpha | 4 | 2015 | 59 | 0.580 |
Why?
|
| alpha-Linolenic Acid | 1 | 2017 | 8 | 0.560 |
Why?
|
| Placentation | 8 | 2021 | 44 | 0.560 |
Why?
|
| Chromatography, Liquid | 3 | 2023 | 374 | 0.560 |
Why?
|
| Glyburide | 1 | 2017 | 35 | 0.560 |
Why?
|
| CD36 Antigens | 2 | 2016 | 35 | 0.540 |
Why?
|
| Placental Insufficiency | 2 | 2019 | 111 | 0.530 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2023 | 449 | 0.530 |
Why?
|
| Chorionic Villi | 6 | 2019 | 22 | 0.530 |
Why?
|
| Ion Transport | 7 | 2009 | 57 | 0.520 |
Why?
|
| Coenzyme A Ligases | 1 | 2016 | 13 | 0.520 |
Why?
|
| Monosaccharide Transport Proteins | 5 | 2004 | 49 | 0.510 |
Why?
|
| Fatty Acid-Binding Proteins | 5 | 2018 | 67 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2021 | 817 | 0.490 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 468 | 0.490 |
Why?
|
| Sodium-Hydrogen Exchangers | 4 | 2002 | 26 | 0.480 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 190 | 0.470 |
Why?
|
| Receptors, Adiponectin | 4 | 2024 | 19 | 0.460 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 373 | 0.460 |
Why?
|
| Folic Acid Deficiency | 3 | 2021 | 48 | 0.450 |
Why?
|
| Labor, Obstetric | 1 | 2014 | 58 | 0.450 |
Why?
|
| Inflammation | 2 | 2015 | 2654 | 0.430 |
Why?
|
| Papio | 6 | 2021 | 91 | 0.430 |
Why?
|
| Fetal Weight | 7 | 2015 | 56 | 0.430 |
Why?
|
| Sodium | 13 | 2020 | 205 | 0.430 |
Why?
|
| Blood Glucose | 8 | 2022 | 2093 | 0.420 |
Why?
|
| Ceramides | 1 | 2014 | 104 | 0.420 |
Why?
|
| Interleukin-6 | 3 | 2015 | 716 | 0.420 |
Why?
|
| RNA, Small Interfering | 5 | 2023 | 571 | 0.420 |
Why?
|
| Leucine | 4 | 2020 | 108 | 0.410 |
Why?
|
| Blotting, Western | 12 | 2010 | 1164 | 0.400 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 203 | 0.390 |
Why?
|
| Mice | 23 | 2025 | 16602 | 0.390 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 1185 | 0.390 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2003 | 35 | 0.390 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2025 | 431 | 0.380 |
Why?
|
| PPAR gamma | 5 | 2022 | 182 | 0.380 |
Why?
|
| Pregnancy Trimester, Third | 5 | 2010 | 107 | 0.360 |
Why?
|
| Arachidonic Acids | 2 | 2022 | 54 | 0.360 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2012 | 159 | 0.350 |
Why?
|
| Placental Circulation | 6 | 2019 | 63 | 0.350 |
Why?
|
| RNA, Messenger | 10 | 2023 | 2675 | 0.350 |
Why?
|
| Young Adult | 12 | 2024 | 12312 | 0.340 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2020 | 78 | 0.330 |
Why?
|
| In Vitro Techniques | 15 | 2012 | 1039 | 0.330 |
Why?
|
| Down-Regulation | 8 | 2018 | 631 | 0.330 |
Why?
|
| Fusion Regulatory Protein 1, Light Chains | 3 | 2020 | 6 | 0.320 |
Why?
|
| Extracellular Vesicles | 2 | 2022 | 129 | 0.320 |
Why?
|
| Term Birth | 3 | 2015 | 20 | 0.320 |
Why?
|
| Protein Kinases | 6 | 2019 | 309 | 0.310 |
Why?
|
| Overweight | 4 | 2015 | 524 | 0.310 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 59 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 2430 | 0.310 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2014 | 59 | 0.310 |
Why?
|
| Decidua | 2 | 2019 | 23 | 0.310 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 262 | 0.310 |
Why?
|
| Metabolic Diseases | 2 | 2020 | 105 | 0.300 |
Why?
|
| Immunohistochemistry | 10 | 2018 | 1664 | 0.300 |
Why?
|
| Organ Size | 10 | 2018 | 440 | 0.300 |
Why?
|
| Immunity, Innate | 1 | 2014 | 802 | 0.290 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2023 | 26 | 0.280 |
Why?
|
| Case-Control Studies | 11 | 2021 | 3328 | 0.280 |
Why?
|
| Male | 30 | 2025 | 62858 | 0.280 |
Why?
|
| Adenosine Triphosphate | 3 | 2006 | 471 | 0.280 |
Why?
|
| Heart Diseases | 2 | 2022 | 345 | 0.280 |
Why?
|
| Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.280 |
Why?
|
| Sex Characteristics | 2 | 2023 | 721 | 0.270 |
Why?
|
| Fatty Liver | 2 | 2022 | 231 | 0.270 |
Why?
|
| Endocrine Disruptors | 2 | 2018 | 40 | 0.270 |
Why?
|
| Hormones | 3 | 2017 | 140 | 0.260 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2006 | 22 | 0.260 |
Why?
|
| Diet, Protein-Restricted | 2 | 2021 | 11 | 0.260 |
Why?
|
| Myocardium | 6 | 2019 | 965 | 0.260 |
Why?
|
| Lipase | 2 | 2015 | 64 | 0.250 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 3 | 2023 | 14 | 0.250 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2022 | 190 | 0.240 |
Why?
|
| Up-Regulation | 8 | 2020 | 825 | 0.230 |
Why?
|
| Cesarean Section | 3 | 2022 | 182 | 0.230 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2004 | 15 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 3 | 2019 | 302 | 0.220 |
Why?
|
| Oxygen | 2 | 2022 | 899 | 0.220 |
Why?
|
| Ether | 1 | 2023 | 7 | 0.220 |
Why?
|
| Ethyl Ethers | 1 | 2023 | 4 | 0.220 |
Why?
|
| Plasmalogens | 1 | 2023 | 6 | 0.220 |
Why?
|
| Ethers | 1 | 2023 | 16 | 0.220 |
Why?
|
| Enzyme Activation | 3 | 2015 | 799 | 0.220 |
Why?
|
| Phosphatidylethanolamines | 1 | 2023 | 74 | 0.210 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 160 | 0.210 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 82 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 269 | 0.210 |
Why?
|
| Embryonic Development | 2 | 2021 | 114 | 0.210 |
Why?
|
| Peptide Hormones | 1 | 2002 | 11 | 0.210 |
Why?
|
| Gene Knockdown Techniques | 3 | 2025 | 312 | 0.200 |
Why?
|
| Leptin | 4 | 2015 | 218 | 0.200 |
Why?
|
| Acyltransferases | 1 | 2022 | 53 | 0.200 |
Why?
|
| Chlorides | 3 | 1998 | 138 | 0.200 |
Why?
|
| Amino Acid Transport System y+ | 2 | 2020 | 8 | 0.200 |
Why?
|
| Rheology | 1 | 2022 | 90 | 0.190 |
Why?
|
| Parathyroid Hormone | 1 | 2002 | 106 | 0.190 |
Why?
|
| Overnutrition | 1 | 2022 | 30 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 270 | 0.190 |
Why?
|
| Phosphates | 1 | 2022 | 168 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 371 | 0.190 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2014 | 12 | 0.190 |
Why?
|
| Esterification | 1 | 2020 | 9 | 0.180 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 185 | 0.180 |
Why?
|
| Mice, Obese | 4 | 2022 | 57 | 0.180 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 940 | 0.180 |
Why?
|
| Biomarkers | 6 | 2022 | 3880 | 0.170 |
Why?
|
| Organogenesis | 1 | 2021 | 56 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 5272 | 0.170 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 93 | 0.170 |
Why?
|
| Serotonin | 2 | 2020 | 317 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2000 | 53 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 226 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 84 | 0.170 |
Why?
|
| Apoptosis | 4 | 2019 | 2435 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 23 | 0.170 |
Why?
|
| Rats, Wistar | 5 | 2021 | 397 | 0.170 |
Why?
|
| NF-kappa B | 2 | 2014 | 649 | 0.160 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2020 | 52 | 0.160 |
Why?
|
| Diabetes Mellitus | 2 | 2010 | 1000 | 0.160 |
Why?
|
| Myometrium | 1 | 2019 | 35 | 0.160 |
Why?
|
| Apelin | 1 | 2019 | 9 | 0.160 |
Why?
|
| Erythrocytes | 1 | 2024 | 672 | 0.160 |
Why?
|
| Developing Countries | 1 | 2021 | 285 | 0.160 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 35 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 163 | 0.150 |
Why?
|
| Infant, Premature | 2 | 2022 | 535 | 0.150 |
Why?
|
| Olive Oil | 1 | 2018 | 3 | 0.150 |
Why?
|
| PPAR delta | 1 | 2018 | 5 | 0.150 |
Why?
|
| Obstetrics | 2 | 2018 | 161 | 0.150 |
Why?
|
| Perilipin-2 | 1 | 2018 | 36 | 0.150 |
Why?
|
| Cytokines | 2 | 2017 | 1983 | 0.150 |
Why?
|
| Phthalic Acids | 1 | 2018 | 45 | 0.140 |
Why?
|
| Piperidines | 1 | 2019 | 190 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 153 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2003 | 300 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2018 | 164 | 0.140 |
Why?
|
| Cohort Studies | 6 | 2022 | 5388 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 815 | 0.140 |
Why?
|
| Lysine | 2 | 2001 | 278 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 391 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 1001 | 0.140 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.140 |
Why?
|
| Kinetics | 7 | 2000 | 1615 | 0.140 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 26 | 0.130 |
Why?
|
| Rats | 11 | 2021 | 5165 | 0.130 |
Why?
|
| Food Deprivation | 1 | 2016 | 21 | 0.130 |
Why?
|
| Muscle Contraction | 1 | 2019 | 420 | 0.130 |
Why?
|
| RNA Interference | 4 | 2021 | 441 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 190 | 0.130 |
Why?
|
| Regulatory-Associated Protein of mTOR | 4 | 2019 | 18 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2018 | 175 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 1999 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 603 | 0.130 |
Why?
|
| Biological Transport, Active | 3 | 2015 | 72 | 0.130 |
Why?
|
| Heart | 5 | 2019 | 635 | 0.130 |
Why?
|
| beta-Alanine | 3 | 2006 | 16 | 0.130 |
Why?
|
| Transcriptome | 2 | 2022 | 881 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2018 | 604 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1484 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 449 | 0.130 |
Why?
|
| Maternal Age | 3 | 2021 | 123 | 0.130 |
Why?
|
| Proteomics | 1 | 2022 | 1009 | 0.120 |
Why?
|
| Liver | 3 | 2023 | 1826 | 0.120 |
Why?
|
| Nanomedicine | 1 | 2016 | 31 | 0.120 |
Why?
|
| Reference Values | 3 | 2002 | 776 | 0.120 |
Why?
|
| Gynecology | 1 | 2018 | 175 | 0.120 |
Why?
|
| Altitude | 1 | 2019 | 447 | 0.120 |
Why?
|
| Extracellular Space | 1 | 1995 | 120 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2019 | 571 | 0.120 |
Why?
|
| Diet | 4 | 2017 | 1199 | 0.120 |
Why?
|
| Adenylate Kinase | 1 | 2014 | 26 | 0.120 |
Why?
|
| Exosomes | 1 | 2016 | 96 | 0.120 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 615 | 0.120 |
Why?
|
| Caspase 10 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Chorionic Gonadotropin | 1 | 2014 | 80 | 0.110 |
Why?
|
| Proteome | 1 | 2018 | 430 | 0.110 |
Why?
|
| Membrane Potentials | 6 | 2003 | 260 | 0.110 |
Why?
|
| Cell Survival | 3 | 2012 | 1077 | 0.110 |
Why?
|
| Caloric Restriction | 1 | 2015 | 108 | 0.110 |
Why?
|
| Weight Gain | 2 | 2015 | 503 | 0.110 |
Why?
|
| Caspase 1 | 1 | 2014 | 142 | 0.110 |
Why?
|
| Models, Biological | 3 | 2019 | 1691 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1020 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2018 | 461 | 0.110 |
Why?
|
| Fetal Diseases | 1 | 2015 | 156 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2013 | 26 | 0.110 |
Why?
|
| Immune System | 1 | 2015 | 176 | 0.110 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2013 | 9 | 0.110 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2013 | 13 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 488 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 3 | 2019 | 135 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 228 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2010 | 3624 | 0.110 |
Why?
|
| Ubiquitination | 3 | 2022 | 98 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2014 | 89 | 0.110 |
Why?
|
| Mitochondria | 2 | 2019 | 848 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 380 | 0.100 |
Why?
|
| Parathyroid Hormone-Related Protein | 2 | 2003 | 24 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2015 | 325 | 0.100 |
Why?
|
| Dietary Fats | 3 | 2011 | 301 | 0.100 |
Why?
|
| Incidence | 1 | 2019 | 2616 | 0.100 |
Why?
|
| Gene Expression | 2 | 2009 | 1456 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 514 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 397 | 0.100 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 3937 | 0.100 |
Why?
|
| Infant | 3 | 2023 | 8914 | 0.100 |
Why?
|
| Cell Fractionation | 2 | 2002 | 56 | 0.100 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 3 | 2019 | 28 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 175 | 0.100 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 238 | 0.100 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 15 | 0.100 |
Why?
|
| Hydrops Fetalis | 1 | 1991 | 13 | 0.100 |
Why?
|
| Polyhydramnios | 1 | 1991 | 17 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2013 | 176 | 0.100 |
Why?
|
| Lactates | 1 | 1991 | 83 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 2620 | 0.090 |
Why?
|
| Lactic Acid | 3 | 2006 | 293 | 0.090 |
Why?
|
| Protein Kinase C | 3 | 2004 | 253 | 0.090 |
Why?
|
| Duodenum | 2 | 2001 | 71 | 0.090 |
Why?
|
| Mass Screening | 1 | 2018 | 1147 | 0.090 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 1057 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 356 | 0.090 |
Why?
|
| Biological Availability | 2 | 2023 | 122 | 0.090 |
Why?
|
| Cell Membrane Permeability | 3 | 1999 | 80 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2011 | 128 | 0.080 |
Why?
|
| Adolescent | 4 | 2019 | 20179 | 0.080 |
Why?
|
| Nickel | 2 | 2003 | 54 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 1275 | 0.080 |
Why?
|
| Sirolimus | 4 | 2018 | 188 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1258 | 0.080 |
Why?
|
| Osmolar Concentration | 4 | 2004 | 164 | 0.080 |
Why?
|
| Proteolysis | 2 | 2022 | 162 | 0.070 |
Why?
|
| Pancreas | 1 | 2010 | 304 | 0.070 |
Why?
|
| Protein Transport | 3 | 2015 | 420 | 0.070 |
Why?
|
| Spleen | 1 | 2010 | 507 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
|
| Food | 1 | 2009 | 155 | 0.070 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2007 | 4 | 0.070 |
Why?
|
| Bicarbonates | 2 | 2001 | 42 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2018 | 1176 | 0.070 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2007 | 28 | 0.070 |
Why?
|
| Guinea Pigs | 4 | 1995 | 155 | 0.070 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2006 | 20 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2018 | 173 | 0.070 |
Why?
|
| Uridine Triphosphate | 1 | 2006 | 12 | 0.070 |
Why?
|
| Muscle Proteins | 2 | 2006 | 221 | 0.070 |
Why?
|
| Health Status | 1 | 2011 | 755 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 2008 | 466 | 0.060 |
Why?
|
| Societies, Scientific | 1 | 2006 | 46 | 0.060 |
Why?
|
| Water | 2 | 1999 | 440 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 5039 | 0.060 |
Why?
|
| Energy Intake | 1 | 2008 | 454 | 0.060 |
Why?
|
| Lentivirus | 1 | 2025 | 52 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2006 | 62 | 0.060 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 1995 | 16 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 345 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 311 | 0.060 |
Why?
|
| Cyclic AMP | 3 | 2002 | 229 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2006 | 304 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 233 | 0.060 |
Why?
|
| Amino Acids, Essential | 1 | 2023 | 13 | 0.060 |
Why?
|
| Child Development | 2 | 2017 | 452 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 323 | 0.050 |
Why?
|
| Sheep | 2 | 2020 | 828 | 0.050 |
Why?
|
| Cytophotometry | 1 | 2003 | 1 | 0.050 |
Why?
|
| Fluorometry | 1 | 2003 | 17 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 62 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2007 | 326 | 0.050 |
Why?
|
| Electrolytes | 1 | 2003 | 58 | 0.050 |
Why?
|
| Computer Systems | 1 | 2003 | 44 | 0.050 |
Why?
|
| Epithelium | 1 | 2004 | 306 | 0.050 |
Why?
|
| Cobalt | 1 | 2003 | 51 | 0.050 |
Why?
|
| Estradiol | 1 | 2006 | 486 | 0.050 |
Why?
|
| Diglycerides | 1 | 2003 | 61 | 0.050 |
Why?
|
| Membrane Fluidity | 2 | 1999 | 11 | 0.050 |
Why?
|
| Umbilical Veins | 2 | 2014 | 58 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2002 | 31 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 198 | 0.050 |
Why?
|
| Mannitol | 2 | 1999 | 35 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 15 | 0.050 |
Why?
|
| Pregnancy, High-Risk | 1 | 2002 | 15 | 0.050 |
Why?
|
| Cholesterol | 3 | 1999 | 406 | 0.050 |
Why?
|
| Urea | 2 | 1999 | 75 | 0.050 |
Why?
|
| Adult Children | 1 | 2022 | 23 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 510 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 7036 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 34 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 112 | 0.050 |
Why?
|
| Carnitine | 1 | 2022 | 76 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 131 | 0.050 |
Why?
|
| ortho-Aminobenzoates | 2 | 1998 | 8 | 0.050 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1998 | 12 | 0.050 |
Why?
|
| Hydrochloric Acid | 1 | 2001 | 8 | 0.050 |
Why?
|
| Time Factors | 3 | 2008 | 6482 | 0.050 |
Why?
|
| Fetal Heart | 1 | 2022 | 55 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 495 | 0.050 |
Why?
|
| Norway | 1 | 2021 | 42 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 88 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2022 | 168 | 0.050 |
Why?
|
| Middle Aged | 2 | 2019 | 30889 | 0.040 |
Why?
|
| Fusion Regulatory Protein 1, Heavy Chain | 1 | 2020 | 2 | 0.040 |
Why?
|
| Monoamine Oxidase | 1 | 2020 | 27 | 0.040 |
Why?
|
| Parity | 1 | 2021 | 120 | 0.040 |
Why?
|
| Adenylyl Cyclases | 1 | 2001 | 82 | 0.040 |
Why?
|
| Vitrification | 1 | 2020 | 7 | 0.040 |
Why?
|
| Ouabain | 1 | 2000 | 18 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 232 | 0.040 |
Why?
|
| Birth Rate | 1 | 2020 | 25 | 0.040 |
Why?
|
| Immune Sera | 1 | 2000 | 86 | 0.040 |
Why?
|
| Embryo Implantation | 1 | 2020 | 27 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 47 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 33 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2020 | 84 | 0.040 |
Why?
|
| Adipocytes | 1 | 2022 | 204 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 142 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2000 | 199 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 357 | 0.040 |
Why?
|
| Mothers | 2 | 2017 | 729 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 86 | 0.040 |
Why?
|
| Heart Ventricles | 2 | 1995 | 765 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 99 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 304 | 0.040 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 25 | 0.040 |
Why?
|
| Apelin Receptors | 1 | 2019 | 4 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2000 | 536 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 14 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 161 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 95 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2000 | 166 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 1999 | 90 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 112 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 42 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 283 | 0.040 |
Why?
|
| Tetrahydrofolates | 1 | 2018 | 18 | 0.040 |
Why?
|
| Mitosis | 1 | 2019 | 178 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 148 | 0.040 |
Why?
|
| Taurine | 1 | 1998 | 40 | 0.040 |
Why?
|
| Environmental Health | 1 | 2018 | 37 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 184 | 0.040 |
Why?
|
| Uterus | 1 | 2019 | 206 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1998 | 123 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 28 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2020 | 376 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 107 | 0.030 |
Why?
|
| Phenotype | 1 | 2005 | 3044 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 85 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2000 | 221 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2011 | 327 | 0.030 |
Why?
|
| Homocysteine | 1 | 2017 | 149 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 2016 | 56 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 575 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 803 | 0.030 |
Why?
|
| Glucose Transporter Type 3 | 2 | 2007 | 13 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 623 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fatty Acid Binding Protein 3 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Membranes | 1 | 1995 | 20 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2015 | 14 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2016 | 29 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2007 | 2239 | 0.030 |
Why?
|
| Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
|
| Temperature | 3 | 1993 | 625 | 0.030 |
Why?
|
| Transport Vesicles | 1 | 2015 | 18 | 0.030 |
Why?
|
| Sarcolemma | 1 | 1995 | 40 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 185 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2015 | 48 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 143 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 210 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1996 | 399 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 101 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2731 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 145 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1995 | 261 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 389 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 589 | 0.030 |
Why?
|
| Ventricular Function | 3 | 1987 | 60 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 893 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2004 | 417 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2017 | 422 | 0.030 |
Why?
|
| Photolysis | 1 | 1993 | 90 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1900 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1993 | 116 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1212 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2013 | 230 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1848 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 1993 | 190 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 1627 | 0.020 |
Why?
|
| Perfusion | 2 | 2004 | 188 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 4892 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2344 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3184 | 0.020 |
Why?
|
| Blood Volume | 1 | 1991 | 60 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 1093 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3772 | 0.020 |
Why?
|
| Ion Channels | 2 | 1988 | 127 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1936 | 0.020 |
Why?
|
| Xanthines | 1 | 1990 | 17 | 0.020 |
Why?
|
| Peptides | 1 | 1995 | 908 | 0.020 |
Why?
|
| Carbamazepine | 1 | 1990 | 18 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1990 | 33 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2015 | 831 | 0.020 |
Why?
|
| Stem Cells | 1 | 2013 | 578 | 0.020 |
Why?
|
| Women's Health | 1 | 2011 | 362 | 0.020 |
Why?
|
| Purines | 1 | 1990 | 169 | 0.020 |
Why?
|
| Colforsin | 1 | 1988 | 49 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2010 | 509 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 3376 | 0.020 |
Why?
|
| Adenosine | 1 | 1990 | 211 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1988 | 107 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 928 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2006 | 35 | 0.020 |
Why?
|
| Action Potentials | 3 | 1988 | 468 | 0.020 |
Why?
|
| Tetrodotoxin | 2 | 1987 | 38 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1987 | 330 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1990 | 499 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2006 | 86 | 0.020 |
Why?
|
| Protons | 1 | 2006 | 80 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2011 | 635 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 1564 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2008 | 715 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2004 | 39 | 0.010 |
Why?
|
| Phosphofructokinases | 1 | 2004 | 7 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 194 | 0.010 |
Why?
|
| Hexokinase | 1 | 2004 | 18 | 0.010 |
Why?
|
| Pyruvate Kinase | 1 | 2004 | 26 | 0.010 |
Why?
|
| Sex Factors | 1 | 2010 | 1945 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 577 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 116 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 10384 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 2722 | 0.010 |
Why?
|
| Methods | 1 | 1981 | 64 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1981 | 95 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2001 | 46 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2000 | 1 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 167 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 1032 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 567 | 0.010 |
Why?
|
| Cell Separation | 1 | 1981 | 313 | 0.010 |
Why?
|
| Wales | 1 | 2000 | 17 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 680 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 1663 | 0.010 |
Why?
|
| Database Management Systems | 1 | 2000 | 48 | 0.010 |
Why?
|
| Medical Audit | 1 | 2000 | 77 | 0.010 |
Why?
|
| Disabled Children | 1 | 2000 | 69 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1998 | 2 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1998 | 52 | 0.010 |
Why?
|
| Antiporters | 1 | 1998 | 22 | 0.010 |
Why?
|
| Filtration | 1 | 1998 | 65 | 0.010 |
Why?
|
| Data Collection | 1 | 2000 | 647 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 336 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1993 | 97 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 1993 | 97 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 1478 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1993 | 405 | 0.010 |
Why?
|
| Light | 1 | 1993 | 354 | 0.010 |
Why?
|
| Phenylisopropyladenosine | 1 | 1990 | 6 | 0.010 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1990 | 10 | 0.010 |
Why?
|
| Clonidine | 1 | 1990 | 27 | 0.010 |
Why?
|
| Theophylline | 1 | 1990 | 64 | 0.010 |
Why?
|
| Caffeine | 1 | 1990 | 61 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1990 | 115 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1988 | 22 | 0.000 |
Why?
|
| Metoprolol | 1 | 1988 | 39 | 0.000 |
Why?
|
| Albuterol | 1 | 1988 | 103 | 0.000 |
Why?
|
| Ryanodine | 1 | 1987 | 14 | 0.000 |
Why?
|
| Egtazic Acid | 1 | 1987 | 41 | 0.000 |
Why?
|
| Nifedipine | 1 | 1987 | 28 | 0.000 |
Why?
|
| Acetylcholine | 1 | 1988 | 181 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1990 | 484 | 0.000 |
Why?
|
| Motor Activity | 1 | 1990 | 668 | 0.000 |
Why?
|